Pregled bibliografske jedinice broj: 633272
Specific Targeted Therapy: A New Tool For The Destruction Of Cancer
Specific Targeted Therapy: A New Tool For The Destruction Of Cancer // Current drug therapy, 8 (2013), 1; 15-23 doi:10.2174/15748855112079990001 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 633272 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Specific Targeted Therapy: A New Tool For The Destruction Of Cancer
Autori
Grdiša, Mirica
Izvornik
Current drug therapy (1574-8855) 8
(2013), 1;
15-23
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Cancer ; drug ; specific targeted therapy ; treatment
Sažetak
Cancer is a worldwide leading cause of death. Multiple genetic mutations or environmental influences lead to the change of cellular functions that result in malignant transformation. Therapeutic approaches, such as surgery, chemotherapy and radiotherapy have harmful side effects due to their inability to specifically target particular tumors. Each therapeutic strategy is aimed to affect the target tumor cells with minimum toxic effects on the function of the normal cells. Specific targeted therapy offers the hope of improving the treatment of cancer resistant to conventional therapy. A better understanding of the molecular pathogenesis of cancer has contributed to the development of specific novel drugs, including monoclonal antibodies, small molecule inhibitors, mimetic, antisense and small interference RNA. The use of cancer vaccines for the specific treatment of cancer has recently increased, as they are able to generate an active tumor-specific immune response. However, the treatment of cancer with specific peptides/proteins, genes, and short interfering RNA (siRNA) is very promising, using cell penetrating peptides for their delivery into the cells. These compounds act on specific targets that are believed to contribute to the development and progression of cancers and the resistance of tumors to conventional therapies. Delivered individually or in combination with chemo- and/or radiotherapy, such novel drugs have produced significant responses in certain types of tumors. This review describes these different strategies which provide some insight into the future direction of the eradication of cancer cells altogether.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Mirica Grdiša
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- Chemical Abs
- PubsHub
- Scopus
- Genamics
- Journal Seek
- J-Gate
- MediaFinder